GlaxoSmithKline (GSK) Reports Mixed Q4 Results

GlaxoSmithKline (NYSE: GSK) reports Q4 non-GAAP earnings of 28.4 pence per share, which compares to the Street estimate of 28.3 pence. Sales came in at £6.98 billion, which compares to the Street estimate of £7.31 billion.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• Is the global equity rally broadening? UBS weighs in